pocketful logo
Lactose (India) Ltd logo

Lactose (India) Ltd

NSE: BSE: 524202

86.11

(-4.83%)

Sat, 28 Mar 2026, 05:04 pm

Lactose (India) Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    98.43

  • Net Profit

    5.16

  • P/B

    2.14

  • Sector P/E

    40.02

  • P/E

    21.63

  • EV/EBITDA

    8.89

  • Debt/Equity (Industry)

    0.16

  • Interest Cover (Industry)

    20.07

  • ROCE (Industry)

    20.49

  • RONW (Industry)

    17.59

  • ROE

    9.75

  • ROCE

    12.69

  • Debt/Equity

    0.91

  • EPS (TTM)

    3.84

  • Dividend Yield

    0

  • Book Value

    49.56

  • Interest Cover

    2.13

Analysis

all

thumbs up icon

Pros

  • Lactose (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Lactose (India) has been profitable on average in the past, therefore cash runway is not a concern.
  • Lactose (India) has been profitable on average in the past, therefore cash runway is not a concern.
  • The level of debt compared to net worth has been reduced over the past 5 years (242.1% vs 111.9% today).
  • The tenure for the Lactose (India) board of directors is about average.
thumbs up icon

Cons

  • Unable to evaluate Lactose (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Lactose (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Debt is not well covered by operating cash flow (5%, less than 20% of total debt).
  • Debt is not covered by short term assets, assets are 0.6x debt.
  • Lactose (India)'s long term commitments exceed its cash and other short term assets.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters53.6553.6553.6553.6553.65
FII00000
DII0.620.620.620.620.62
Public45.7445.7445.7445.7445.74
Government00000

Read More

Technical Analysis

RSI

32.99

MACD

-3.98

50 DMA

95.48

200 DMA

107.14

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic136.12118.29106.90100.4689.0782.6364.80
Fibonacci118.29111.48107.27100.4693.6589.4482.63
Camarilla100.4198.7897.14100.4693.8892.2490.61

Pivots Level: Classic

R3

+35.66

136.12

R2

+17.83

118.29

R1

+6.44

106.90

100.46
100.46
Pivot Point
LTP: 78.19

S1

-11.39

89.07

S2

-17.83

82.63

S3

-35.66

64.80

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    85.91

  • 20-EMA

    89.27

  • 30-EMA

    91.57

  • 50-EMA

    95.15

  • 100-EMA

    101.13

  • 200-EMA

    109.02

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
26 Feb 2026egm
13 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
16 Sept 2025agm
24 Oct 2024egm
09 Sept 2024agm
16 Aug 2023agm
26 May 2022agm
06 Sept 2021agm

Read More

Peer Comparison

Lactose (India) Ltd logo

Lactose (India) Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Lupin Ltd logo

Lupin Ltd

Read More

Lactose (India) Ltd About

Lactose (India) is a Pharmaceutical Company and engaged in the Business of Manufacturing, trading and carrying out job work and manufacturing of Pharmaceutical Products.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1991

Headquarters

CEO

Atul Maheshwari

Employees

Contact

Website icon

Website

http://www.lactoseindialimited.com

Email icon

Email

lil@lactoseindialimited.com, cs.lactose@gmail.com

Phone icon

Phone

91-02667-244308/244729

Location icon

Location

Survey No 6, Village Poicha (Rania) Savli, Vadodara, Gujarat, 391780

Read More

Lactose (India) Ltd Company History

YearHistory
2007
  • Lactose India designated an email ID for investor complaints.
2015
  • Lactose (India) started manufacturing for Dr. Reddy's for their liquid oral bottles.
2016
  • Lactose (India) started lactulose manufacturing API plant, a Make In India product.
2018
  • The company made a strategic alliance with Solactis SAS France for Prebiotic.
2022
  • Lactose (India) ended up the contract with Kerry and started its own marketing and sales of Lactose Monohydrate under the banner of Lactose (India) Limited.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
ANKIT AGARWALSell86562147.929 Feb 2024
MABLE RAJESHBuy5100028.0122 Apr 2019
MANGAL SAVITRI BIZCON PRIVATE LIMITEDSell10927712023 Feb 2018
MANGAL SAVITRI BIZCON PRIVATE LIMITEDBuy86903188.7712 Sept 2017
SANTOSH BHANSALI HUFSell7600018531 Aug 2017
ALAUKIK MINES AND POWER P LTDSell7330013011 Jul 2017
ALAUKIK MINES AND POWER P LTDBuy5530015515 Jun 2017
MANGAL SAVITRI BIZCON PRIVATE LIMITEDSell5395015515 Jun 2017
MANGAL SAVITRI BIZCON PRIVATE LIMITEDBuy10346146.1515 Jun 2017
RAJESH JOSEPHBuy49000115.1724 May 2017

Read More

Lactose (India) Ltd News

Lactose India Completes NCLT Meeting for Merger Approval

Lactose (India) Limited successfully conducted NCLT convened meeting on March 28, 2026, for scheme of amalgamation with Vitanosh Ingredients Private Limited, with results to be reported to NCLT Ahmedabad Bench.

28 Mar 2026

companies

Lactose India Issues EGM Corrigendum for March 28 Merger

Lactose (India) Limited issues corrigendum to EGM notice for March 28, 2026, providing additional SEBI-mandated disclosures on merger with Vitanosh Ingredients, including shareholding changes and financial implications.

27 Mar 2026

companies

Lactose India Expands Into Value-Added Pharma Products

Lactose (India) Limited announces adoption of new business line in specialized pharmaceutical excipients with ₹15 crore investment, launching four value-added lactose products for domestic market.

30 Jan 2026

stocks

SST Private Family Trust Files SEBI Disclosure

SST Private Family Trust filed regulatory disclosure with SEBI on January 14, 2026, for its 4.57% stake acquisition in Lactose (India) Limited, paying ₹1.77 lakh in fees.

10 Dec 2025

co actions results

SST Private Family Trust Completes 4.57% Stake Transfer

SST Private Family Trust successfully completed acquisition of 5.75 lakh shares (4.57% stake) in Lactose (India) Limited from Madhusha Lifecare Private Limited on December 17, 2025.

10 Dec 2025

co actions results

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800